Progyny authorizes repurchase of up to $200M in shares using existing cash reserves, signaling confidence in its financial position.
Progyny’s board approved a $200M share repurchase program, allowing the company to buy back its common stock. The initiative will be funded through available cash balances, reflecting liquidity strength.
The move follows a premarket share price increase of 1.6% to $25.28. No prior repurchase program of this scale has been announced by the company in recent years.
Shares reacted positively in premarket trading, indicating investor approval of the capital allocation strategy.